John M. Gay
CIK: 0001765684
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PTHS
Pelthos Therapeutics Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About GAY JOHN M.
GAY JOHN M. (SEC CIK 0001765684) files insider reports with the SEC as Chief Financial Officer of Pelthos Therapeutics Inc. (PTHS).
Signal8 holds 1 ownership filing by GAY JOHN M., a Form 3, filed on Apr 20, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on GAY JOHN M.'s filings is in DURHAM, NC.
Other insiders filing for Pelthos Therapeutics Inc. (PTHS)
- Greenleaf Peter, Director
- Friedberg Ezra M, Director
- Pauls Matthew, Director
- Davis Todd C, Director
- Francis Knuettel II, CFO, Treas & Secty
- Malamut Richard, Director